These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 501215)

  • 21. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.
    Schneider JF; Baker AL; Haines NW; Hatfield G; Boyer JL
    Gastroenterology; 1980 Dec; 79(6):1145-50. PubMed ID: 6777231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ranitidine disposition in severe hepatic cirrhosis.
    Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver function and medroxyprogesterone acetate elimination in man.
    Rautio A
    Biomed Pharmacother; 1984; 38(4):199-204. PubMed ID: 6498308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.
    Debruyne D; Gram LF; Grollier G; Camsonne R; Agron L; Dao MT; Lacotte J; Bigot MC; Moulin M
    Int J Clin Pharmacol Res; 1989; 9(5):319-25. PubMed ID: 2625371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of alcoholic cirrhosis with enzyme inducers.
    Rautio A; Sotaniemi EA; Pelkonen RO; Luoma PV
    Clin Pharmacol Ther; 1980 Nov; 28(5):629-37. PubMed ID: 7438682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.
    Døssing M; Pilsgaard H; Rasmussen B; Poulsen HE
    Eur J Clin Pharmacol; 1983; 25(2):215-22. PubMed ID: 6628504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis.
    Larrey D; Lebrec D; Bercoff E; Pessayre D
    Clin Sci (Lond); 1983 Aug; 65(2):203-5. PubMed ID: 6602683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of different methods expressing results of the aminopyrine breath test.
    Schoeller DA; Baker AL; Monroe PS; Krager PS; Schneider JF
    Hepatology; 1982; 2(4):455-62. PubMed ID: 6807795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminopyrine breath test in alcoholic liver disease and in patients on enzyme-inducing drugs.
    Lewis KO; Nicholson G; Lance P; Paton A
    J Clin Pathol; 1977 Nov; 30(11):1040-3. PubMed ID: 591642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of hepatic microsomal enzyme activity using C-l4-labeled aminopyrine breath test in patients with diabetes mellitus type 2 treated with tolbutamide].
    Kamińska-Galwas B; Sroczyński J
    Pol Arch Med Wewn; 1991 Sep; 86(3):142-8. PubMed ID: 1808599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal vitamin D metabolism in patients with cirrhosis.
    Hepner GW; Roginsky M; Moo HF
    Am J Dig Dis; 1976 Jul; 21(7):527-32. PubMed ID: 181983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some factors affecting liver microsomal drug metabolism in the chicken.
    Drummond AH; McCall JM; Jondorf WR
    Biochem J; 1972 Nov; 130(2):73P-74P. PubMed ID: 4664600
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of alcohol abuse and glutathione administration on the circulating levels of glutathione and on antipyrine metabolism in patients with alcoholic liver cirrhosis.
    Loguercio C; Piscopo P; Guerriero C; De Girolamo V; Disalvo D; Del Vecchio Blanco C
    Scand J Clin Lab Invest; 1996 Aug; 56(5):441-7. PubMed ID: 8869667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of age and sex on the N-demethylation rate of 14C-aminopyrine, studied by the breath test.
    Pirotte J; El Allaf D
    Digestion; 1983; 28(4):210-5. PubMed ID: 6671482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in the disposition of differently cleared drugs in patients with cirrhosis.
    Klotz U; Fischer C; Müller-Seydlitz P; Schulz J; Müller WA
    Clin Pharmacol Ther; 1979 Aug; 26(2):221-7. PubMed ID: 455890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of cirrhosis of the liver on microsomal detoxications and cytochrome P-450.
    Marshall WJ; McLean AE
    Br J Exp Pathol; 1969 Dec; 50(6):578-83. PubMed ID: 5364388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low selenium status in alcoholic cirrhosis is correlated with aminopyrine breath test. Preliminary effects of selenium supplementation.
    Van Gossum A; Nève J
    Biol Trace Elem Res; 1995; 47(1-3):201-7. PubMed ID: 7779548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.